Juan Benet built Protocol Labs on the IPFS file system and the Filecoin storage network. He is now raising a venture fund for the brain.
PLC Neurotech Fund I LP filed a notice of an exempt securities offering, known as a Form D, with the US Securities and Exchange Commission on 29 October. The fund was formed in Delaware this year and is based in Austin, Texas. Its general partner is PLC Neurotech GP I LLC, whose sole member is Juan Batiz-Benet, the name under which Benet appears in Protocol Labs’ own SEC filings. PLC Neurotech’s website describes it as a newly formed investment adviser that seeks to raise and manage funds investing in brain-computer interfaces, neuroscience-oriented AI and connectomics, the mapping of the brain’s wiring.
What the filing shows
The fund had not raised any money when it filed. The Form D lists no sales, no investors and no first sale yet, and gives the offering size as indefinite. A related entity, PLC Neurotech MGMT LP, is named as the fund’s investment manager. The filing claims the Rule 506(c) exemption, which lets a fund advertise its offering publicly if every buyer is an accredited investor, the fund takes reasonable steps to verify that status, and other conditions of the SEC’s Regulation D are met.
Where PLC Neurotech already appears
The name has already turned up in a deal. On 17 November, Science Corporation listed PLC Neurotech among the investors in its $400 million Series D, and TechCrunch named it among the backers. Science’s LinkedIn post used the name Protocol Labs in the same list. Protocol Labs’ 8 April post announcing Benet’s podcast, with Science chief executive Max Hodak as the first guest, describes Science as a PLC Neurotech portfolio company.
PLC Neurotech’s website lists a selection of its portfolio: Echo, EON, Hemispheric, Integral Neuro, Merge Labs, Netholabs, Paradromics, Precision, Science and Synchron. Its legal disclosures say these holdings may sit in affiliated vehicles or warehousing arrangements before being allocated to its funds, and that they illustrate the investing experience of the wider PL Capital network. Its venture partner is Sean Escola, a neuroscientist and co-founder of Herophilus.
The research arm
Benet also runs PL Neuro, a Protocol Labs programme that publishes research and funds work across neurotechnology. Its advisers include Hodak, Eddie Chang of UCSF and Echo Neurotechnologies, Adam Marblestone of Convergent Research, Doris Tsao of Astera, Greg Wayne of Google DeepMind and Matthew Botvinick of Anthropic.
On 26 October, PL Neuro published Roadmap 4 of its BCI Roadmap Series, on increasing venture capital flows into the field. It proposes a ten-year strategy built on investment in software and data ventures, an ecosystem the authors call the “Neuro-App Layer”, along with broader demonstrations of what neural interfaces can do and reimbursement for the ongoing software services that keep adaptive devices safe and effective. Benet is one of its ten authors.
On 19 November, PL Neuro launched Neuro Atlas, a public online resource that tracks company and clinical milestones, technical progress such as how many neurons can be recorded at once, and funding through a BCI Funding Index.
Signal: Why it matters
Once it raises money, a fund dedicated to brain-computer interfaces, neuroscience-oriented AI and connectomics would give companies in the field an investor focused on their work. Benet’s group has argued in its roadmap that neurotechnology needs more venture capital to scale beyond single-product medical devices. It also publishes a funding index covering 25 selected BCI companies, which notes that Protocol Labs and PL Capital hold, or may hold, financial interests in companies or funds it features.
Not disclosed
How large the fund aims to be, and who will invest in it. Which vehicle holds the companies listed on PLC Neurotech’s website, and which vehicle invested in Science’s Series D, and how much. How PLC Neurotech is owned in relation to Protocol Labs.
Forward Radar: What to watch
Any announcement of the fund’s first close and the amount raised.
The fund’s first investments.
Further papers in the roadmap series and updates to Neuro Atlas.
Sources
Primary:
- SEC: Form D, PLC Neurotech Fund I LP, 29 October 2026
- PLC Neurotech, PL Capital
- PL Capital: Legal and disclaimers
- PL Neuro: BCI Funding Index, Neuro Atlas
- PL Neuro
- PL Neuro: PL BCI Roadmap Series, Roadmap 4, Increasing Venture Capital Flows, 26 October 2026
- PL Neuro: Introducing Neuro Atlas, 19 November 2026
- Protocol Labs: Announcing the Juan Benet Podcast, 8 April 2026
- Science Corporation: Science Series D, 17 November 2026
Coverage:
Cross-reference to prior InsideBCI coverage: